Liu L, Wang L, Ding Y, Zhang Q, Shu Y
BMJ Open. 2025; 15(3):e094804.
PMID: 40050065
PMC: 11887288.
DOI: 10.1136/bmjopen-2024-094804.
Courtney P, Venkat P, Shih Y, Chang A, Lee A, Steinberg M
JAMA Netw Open. 2025; 8(3):e250033.
PMID: 40036034
PMC: 11880949.
DOI: 10.1001/jamanetworkopen.2025.0033.
Ho K, Pakes A
Proc Natl Acad Sci U S A. 2025; 122(9):e2418540122.
PMID: 39999179
PMC: 11892685.
DOI: 10.1073/pnas.2418540122.
Cai Q, You S, Huang J, Gong C, Zhang W, Zhou A
Hum Vaccin Immunother. 2025; 21(1):2468070.
PMID: 39989197
PMC: 11853545.
DOI: 10.1080/21645515.2025.2468070.
Pearson B, Walker M, Tempero J, Ong K, Lucas P
Cannabis. 2025; 8(1):81-94.
PMID: 39968489
PMC: 11831900.
DOI: 10.26828/cannabis/2024/000239.
Which treatment strategy for irreparable rotator cuff tears is most cost-effective? A Markov model-based cost-utility analysis comparing superior capsular reconstruction, lower trapezius tendon transfer, subacromial balloon spacer implantation and....
Oeding J, Kunze K, Pareek A, Samuelsson K
J Exp Orthop. 2025; 12(1):e70180.
PMID: 39949712
PMC: 11822265.
DOI: 10.1002/jeo2.70180.
Estimating the Cost-Effectiveness of Tumor Treating Fields (TTFields) Therapy with an Immune Checkpoint Inhibitor or Docetaxel in Metastatic Non-Small Cell Lung Cancer.
Furnback W, Wu E, Koh C, Nino de Rivera Guzman J, Kruhl C, Kotecha R
Clinicoecon Outcomes Res. 2025; 17:55-68.
PMID: 39931252
PMC: 11807771.
DOI: 10.2147/CEOR.S501532.
Cost-effectiveness of Transcendental Meditation (TM) for treating Post-Traumatic Stress Disorder (PTSD).
Groessl E, Rutledge T
PLoS One. 2025; 20(2):e0316995.
PMID: 39913396
PMC: 11801526.
DOI: 10.1371/journal.pone.0316995.
Cost-effectiveness of continuous real-time intracardiac recurrent event detection and alerting in high-risk acute coronary syndrome patients.
Sanders Schmidler G, John M, Voigt J, Krucoff M
Future Cardiol. 2025; 21(2):83-93.
PMID: 39885802
PMC: 11812367.
DOI: 10.1080/14796678.2025.2457831.
Comparative- and Cost-Effectiveness Research Determining the Optimal Intervention for Advancing Transgender Women With HIV to Full Viral Suppression (Text Me, Alexis!): Protocol for a Randomized Controlled Trial.
Reback C, Blue T, Jalali A, Landovitz R, Li M, Mata R
JMIR Res Protoc. 2025; 14:e65313.
PMID: 39847410
PMC: 11803334.
DOI: 10.2196/65313.
Understanding and Managing Pediatric Urinary Tract Infections in Vesicoureteral Reflux: Insights Into Pathophysiology and Care.
Alyasi A, Alsaad D, Alshammary E, Abdulrahman A, Ghazwani M, Almuayrifi M
Cureus. 2025; 16(12):e76144.
PMID: 39835023
PMC: 11745421.
DOI: 10.7759/cureus.76144.
Cost-effectiveness analysis of durvalumab with chemotherapy and maintenance durvalumab with or without olaparib for advanced endometrial cancer.
Zhang J, Lei J, You C, Fu W, Zheng B, Cai H
Sci Rep. 2025; 15(1):2497.
PMID: 39833233
PMC: 11747165.
DOI: 10.1038/s41598-025-86021-y.
Is first-line treatment with polatuzumab vedotin-rituximab-cyclophosphamide, doxorubicin and prednisone (pola-R-CHP) for previously untreated diffuse large B-cell lymphoma cost-effective in China? A cost-effectiveness analysis using a Markov model.
Dong L, Zhong W, Chen T, Zhao Q, Liu W, Qiu X
BMJ Open. 2025; 15(1):e086251.
PMID: 39832983
PMC: 11751847.
DOI: 10.1136/bmjopen-2024-086251.
Adding automated breast ultrasound to mammography in women with increased breast density or at an elevated risk of breast cancer is a cost-effective screening strategy.
Grady I, Grady S, Chanisheva N
Cancer Causes Control. 2025; .
PMID: 39752002
DOI: 10.1007/s10552-024-01958-1.
Hospital-based health technology assessment of a screening rapid test MTBI (GFAP and UCH-L1 blood biomarkers) for mild traumatic brain injury.
Menacho Roman M, Penedo Alonso J, Morales Rodriguez A, Pecharroman de Las Heras I, Vicente Bartulos A, Arribas Gomez I
Int J Technol Assess Health Care. 2024; 41(1):e5.
PMID: 39653609
PMC: 11703612.
DOI: 10.1017/S026646232400477X.
Cost-effectiveness analysis of tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma: perspectives from the United States and China.
Lang W, Ai Q, Zhang W, Jiang Q, He Y, Ouyang M
Front Pharmacol. 2024; 15:1461571.
PMID: 39635432
PMC: 11614636.
DOI: 10.3389/fphar.2024.1461571.
Cost-effectiveness analysis of immune checkpoint inhibitors combined with targeted therapy and chemotherapy for HPV/HIV-related cervical cancer.
Liang Y, Ma A
Medicine (Baltimore). 2024; 103(48):e40678.
PMID: 39612459
PMC: 11608711.
DOI: 10.1097/MD.0000000000040678.
Management of monochorionic diamniotic twin gestation affected by Type-II selective fetal growth restriction: cost-effectiveness analysis.
Morgan J, Rios J, Kahl T, Prasad M, Rausch A, Longman R
Ultrasound Obstet Gynecol. 2024; 65(1):39-46.
PMID: 39602652
PMC: 11693837.
DOI: 10.1002/uog.29135.
Cost-Effectiveness of Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder.
Lu T, Ryan D, Cadet T, Chawarski M, Coupet E, Edelman E
Ann Emerg Med. 2024; 85(3):205-213.
PMID: 39570250
PMC: 11845297.
DOI: 10.1016/j.annemergmed.2024.10.001.
Cost-Effectiveness of Computer-Assisted Cognitive Behavioral Therapy for Depression Among Adults in Primary Care.
Ali S, Alemu F, Owen J, Eells T, Antle B, Lee J
JAMA Netw Open. 2024; 7(11):e2444599.
PMID: 39541120
PMC: 11565263.
DOI: 10.1001/jamanetworkopen.2024.44599.
